Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance C Marzolini, E Paus, T Buclin, RB Kim Clinical Pharmacology & Therapeutics 75 (1), 13-33, 2004 | 1263 | 2004 |
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients C Marzolini, A Telenti, LA Decosterd, G Greub, J Biollaz, T Buclin Aids 15 (1), 71-75, 2001 | 1139 | 2001 |
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes A Pascual, T Calandra, S Bolay, T Buclin, J Bille, O Marchetti Clinical infectious diseases 46 (2), 201-211, 2008 | 1036 | 2008 |
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study J Fellay, C Marzolini, ER Meaden, DJ Back, T Buclin, JP Chave, ... The Lancet 359 (9300), 30-36, 2002 | 847 | 2002 |
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence CB Eap, T Buclin, P Baumann Clinical pharmacokinetics 41, 1153-1193, 2002 | 776 | 2002 |
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients S Ostermann, C Csajka, T Buclin, S Leyvraz, F Lejeune, LA Decosterd, ... Clinical cancer research 10 (11), 3728-3736, 2004 | 601 | 2004 |
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients M Rotger, S Colombo, H Furrer, G Bleiber, T Buclin, BL Lee, O Keiser, ... Pharmacogenetics and genomics 15 (1), 1-5, 2005 | 490 | 2005 |
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients S Lavoie, MM Murray, P Deppen, MG Knyazeva, M Berk, O Boulat, ... Neuropsychopharmacology 33 (9), 2187-2199, 2008 | 450 | 2008 |
Towards a new combination therapy for tuberculosis with next generation benzothiazinones V Makarov, B Lechartier, M Zhang, J Neres, AM van der Sar, SA Raadsen, ... EMBO molecular medicine 6 (3), 372-383, 2014 | 425 | 2014 |
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection C Csajka, C Marzolini, K Fattinger, LA Décosterd, J Fellay, A Telenti, ... Clinical pharmacology & therapeutics 73 (1), 20-30, 2003 | 348 | 2003 |
Diet acids and alkalis influence calcium retention in bone T Buclin, M Cosma, M Appenzeller, AF Jacquet, LA Decosterd, J Biollaz, ... Osteoporosis International 12, 493-499, 2001 | 317 | 2001 |
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib A Haouala, N Widmer, MA Duchosal, M Montemurro, T Buclin, ... Blood, The Journal of the American Society of Hematology 117 (8), e75-e87, 2011 | 308 | 2011 |
Antidepressants for the treatment of chronic pain B Verdu, I Decosterd, T Buclin, F Stiefel, A Berney Drugs 68, 2611-2632, 2008 | 300 | 2008 |
Renal drug transporters and drug interactions A Ivanyuk, F Livio, J Biollaz, T Buclin Clinical pharmacokinetics 56, 825-892, 2017 | 241 | 2017 |
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics–based analysis of adult patients with invasive … A Pascual, C Csajka, T Buclin, S Bolay, J Bille, T Calandra, O Marchetti Clinical infectious diseases 55 (3), 381-390, 2012 | 238 | 2012 |
Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein N Widmer, LA Decosterd, C Csajka, S Leyvraz, MA Duchosal, A Rosselet, ... British journal of clinical pharmacology 62 (1), 97-112, 2006 | 225 | 2006 |
The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial C Mazzocato, T Buclin, CH Rapin Annals of Oncology 10 (12), 1511-1514, 1999 | 209 | 1999 |
Benchmarking therapeutic drug monitoring software: a review of available computer tools A Fuchs, C Csajka, Y Thoma, T Buclin, N Widmer Clinical pharmacokinetics 52, 9-22, 2013 | 201 | 2013 |
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function F Lamoth, T Buclin, A Pascual, S Vora, S Bolay, LA Decosterd, T Calandra, ... Antimicrobial agents and chemotherapy 54 (10), 4360-4367, 2010 | 197 | 2010 |
Gender medicine and oncology: report and consensus of an ESMO workshop AD Wagner, S Oertelt-Prigione, A Adjei, T Buclin, V Cristina, C Csajka, ... Annals of Oncology 30 (12), 1914-1924, 2019 | 184 | 2019 |